SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-009673
Filing Date
2024-03-12
Accepted
2024-03-12 16:30:40
Documents
1
Period of Report
2024-03-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6981
  Complete submission text file 0001493152-24-009673.txt   9625
Mailing Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022 2128473500
GOLDENTREE ASSET MANAGEMENT LP (Reporting) CIK: 0001278951 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 24742569

Mailing Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address
Tananbaum Steven A. (Reporting) CIK: 0001435626 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 24742567

Mailing Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 21ST FLOOR NEW YORK NY 10022 212-847-3500
GoldenTree Asset Management LLC (Reporting) CIK: 0001435627 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 24742568

Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15 353 1 6960000
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

IRS No.: 981088325 | Fiscal Year End: 1229
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)